Hodgkin Lymphoma

What is Hodgkin lymphoma?

Hodgkin lymphoma, sometimes called Hodgkin’s Disease, is a cancer that starts in the lymphatic tissue. Lymphatic tissue is found in the lymph nodes and related organs (spleen, bone marrow, tonsils and thymus) that make up the body’s immune and blood-forming systems. Lymphomas are divided into two general types: Hodgkin lymphoma and non-Hodgkin lymphoma. Hodgkin lymphoma can occur in both adults and children.

What causes Hodgkin lymphoma?

Lymph nodes make and store infection-fighting white blood cells called lymphocytes. The cancer cells in Hodgkin Lymphoma are called Reed-Sternberg cells (after two doctors who discoverd them). Reed-Sternberg cells are a type of malignant B lymphocyte and distinguish Hodgkin lymphoma from other types of lymphoma.

Being young or in late adulthood, being male, being infected with the Epstein-Barr virus, and having a first-degree relative with the disease all increase the risk of developing Hodgkin lymphoma.

How is Hodgkin lymphoma diagnosed?

The most common early sign of Hodgkin lymphoma is a painless swelling in the lymph nodes of the neck, upper chest, interior of the chest, armpit, abdomen, or groin. Other symptoms include fever, sweating (especially at night), weight loss, and itching. While uncommon, some people may feel pain in the lymph nodes after drinking alcohol, a distinctive sign of Hodgkin lymphoma. In some cases the spleen is enlarged.

One of the unique features of Hodgkin lymphoma is the way it spreads. It usually begins in the lymph nodes in one region of the body, and as the disease progresses, spreads predictably from one part of the lymph system to the next before finally moving into organs, including the lungs, liver, bone, and bone marrow.

The diagnosis of Hodgkin lymphoma requires the biopsy of an involved lymph node or tumor site. The presence of Reed-Sternberg cells distinguishes Hodgkin lymphoma from other types of lymphomas. Doctor’s may use the following tests to diagnose and stage Hodgkin lymphoma:

  • Physical examination and history
  • Complete blood count, sedimentation rate and other blood work
  • Computed tomography (CT) of the neck, chest, abdomen or pelvis
  • Positron emission tomography (PET) scan
  • Bone marrow biopsy
  • Chest x-ray


There are five different types of Hodgkin lymphoma: nodular sclerosing Hodgkin lymphoma, (by far the most common) mixed cellularity Hodgkin lymphoma, lymphocyte depletion Hodgkin lymphoma, Lymphocyte-rich classical Hodgkin lymphoma, and nodular lymphocyte-predominant Hodgkin lymphoma.

Once Hodgkin lymphoma has been diagnosed, tests may be conducted to see if the cancer has spread. The spread of most cancers is usually described as stages. There are four stages of Hodgkin lymphoma.

  • Stage I – the apparent involvement of a single lymph node region or a single organ, such as bone.
  • Stage II – the involvement of two or three lymph node regions that are close to each other.
  • Stage III – the involvement of several lymph node regions in the neck, chest, and abdomen.
  • Stage IV – widespread involvement of lymph nodes and other organs such as the lungs, liver, and bone.


The four stages of Hodgkin lymphoma are divided into A, B, E, and S. In A, the patient has no symptoms of the disease. In B, the patient has symptoms like fever, weight loss, or night sweats. In E, the cancer has been found in an area or organ other than the lymph nodes or has spread to tissues beyond, but near, the major lymphatic areas. In S, the cancer has spread to the spleen.

What are the treatment options?

The prognosis (chance of recovery) and treatment options depend on the patient’s symptoms, stage of cancer, type of Hodgkin lymphoma, blood test results and the patient’s age, gender, and general health. Whether the cancer is recurrent (has come back) or progressive (is spreading aggressively) also affect treatment options. Adult Hodgkin lymphoma can usually be cured if found and treated early.

Stage I Treatments:
  • Stage IA
    • Combination chemotherapy with or without radiation therapy
    • Radiation therapy to lymph nodes in the neck
    • Clinical trial of combination chemotherapy with or without radiation therapy
    • Radiation therapy to the groin
    • Clinical trials
  • Stage IB
    • Combination chemotherapy with or without radiation therapy


Stage II Treatments:
  • Stage IIA
    • Combination chemotherapy with or without radiation therapy
    • Clinical trials
  • Stage IIB
    • Chemotherapy with or without radiation therapy


Stage III Treatments:
  • Stage IIIA
    • Combination chemotherapy with or without radiation therapy
  • Stage IIIB
    • Combination chemotherapy with or without radiation therapy


Stage IV Treatments:
  • Combination chemotherapy

Recurrent Treatments
  • Combination chemotherapy
  • Combination chemotherapy followed by high-dose chemotherapy and stem cell transplantation with or without radiation therapy (usually the best option)
  • Radiation therapy with or without chemotherapy
  • Chemotherapy as palliative therapy to relieve symptoms and improve quality of life
  • Clinical trial of high-dose chemotherapy and stem cell transplantation



Related Patients & Caregivers Links: THE BASICS, PLANNING FOR TRANSPLANT, THE POST-TRANSPLANT PROCESS, THE PRE-TRANSPLANT PROCESS, THE TRANSPLANT PROCESS
Related News: Full delivery of BEACOPP-14 chemotherapy for high-risk Hodgkin lymphoma enabled by pegfilgrastim support, Hodgkin lymphoma cellular composition influenced by interleukin-9 expression, Hodgkin lymphoma pathogenesis linked to inflammation caused by Epstein-Barr virus, Hodgkin lymphoma involves high expression of activating transcription factor 3, Lymphoma foundation launches educational initiative targeting multicultural populations, Lymphoma response to methotrexate might be affected by reduced folate carrier 1 polymorphisms, Hodgkin-Reed-Sternberg cells inhibit apoptosis via caspase-3 interference, An Interactive Dialog on Myeloma, Lymphoma and Leukemia: Clinical Integration of Recent Advances was held in Scottsdale on May 20, 2006, Lymphoma and leukemia diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy, Lung cancer screened for in Hodgkin lymphoma survivors by computed tomography, Transduction of cytotoxic T lymphocytes may be safe for cancer treatment, Allo-SCT using cord blood or matched-sibling donors comparable in advanced Hodgkin lymphoma, Lymphoma evaluated postoperatively by value of FDG triple-head coincidence PET, University of California researchers report new molecule that targets leukemia and lymphoma cells, Imatinib mesylate treats secondary malignancy with favorable outcome, Lymphoma apoptosis was induced by down-regulating constitutive activation of the nuclear factor-kappa B (NF-kappa B) canonical pathway, Phosphatidylinositol-3 kinase (PI3K)/Akt inhibition promoted apoptosis in Hodgkin lymphoma (HL), Gemcitabine was used as a frontline treatment for cutaneous T-cell lymphoma (CTCL), Investigators review the antigen-specific cellular immunotherapy of leukemia in a recent issue of the journal Leukemia, Diagnosis of secondary malignancies after successful primary treatment of malignant Hodgkin lymphoma (HL) could be difficult, Unrelated cord blood transplantation feasible in adults with high-risk malignancy, Incidence of leukemia, lymphoma, and multiple myeloma in Czech uranium miners studied, Risk for Hodgkin lymphoma may be modifiable through strenuous physical activity, Hodgkin lymphoma treatment with BEACOPP proposed as new standard, Malignant lymphoma was associated with chromosome band 6q deletion pattern, A novel intradermal idiotype vaccine elicited specific immune responses in patients with advanced B-cell lymphoma despite profound immunosuppression, Vaccination with idiotypic protein or DNA failed to prolong dormancy in mice with BCL1 lymphoma, B cell lymphoma could be linked to inactivation of the PR domain containing 1 with zinc finger domain (PRDM1)/B lymphocyte-induced maturation protein 1 (BLIMP1) gene, Hodgkin lymphoma patients did not benefit more from radiotherapy than consolidation chemotherapy, The risk of acute myeloid leukemia (AML) associated with treatments for Hodgkin lymphoma was assessed, Hodgkin lymphoma patients did not benefit more from radiotherapy than consolidation chemotherapy, Breast-feeding of more than 6 months could prevent childhood lymphoid malignancies, especially for acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML), Staging and follow-up of pediatric lymphomas could be conducted with F-18 FDG-PET imaging, Hodgkin lymphoma patients with bulky lymph nodes estimated by power Doppler ultrasound scanning, Malignancies and infections cause late nonrelapse mortality after stem cell transplantation, cIAP2 disfunction was implicated in mucosa-associated lymphoid tissue (MALT) lymphomas, The biology of mucosa-associated lymphoid tissue (MALT) lymphoma was discussed, Pretransplantation factors predict for treatment-related myelodysplastic syndrome after SCT, Single-dose pegfilgrastim induces stem cell mobilization in malignant lymphoma or multiple myeloma, Advanced Hodgkin lymphoma (HL) patients did not benefit more from radiotherapy (RT) than consolidation chemotherapy (CT) after a doxorubicin-induced CR, EBV-associated gastric diffuse large B-cell lymphomas might be resistant to standard chemoradiotherapy, Salvage radiotherapy was deemed safe and effective for select patients with Hodgkin lymphoma after chemotherapy failure, Primary cutaneous marginal zone B-cell lymphoma (PCMZL) was linked to aberrant nuclear B-cell lymphoma 10 (BCL10) expression, but not t(11;18)(Q21;q21) translocation, Hodgkin lymphoma response monitoring by FDG-PET explained, Expression of CT45 in Hodgkin lymphoma is characterized, Low-grade lymphoma progression to high-grade disease observed by FDG-PET, Findings from Children's Hospital in lymphoma in children reported, Hodgkin lymphoma prevented by alcohol drinking, Hodgkin lymphoma residual disease and relapse detected by FDG-PET
Related Keywords: Nodular Lymphocyte-Predominant Hodgkin Lymphoma, Lymphocyte-Rich Classical Hodgkin Lymphoma, Lymphocyte Depletion Hodgkin Lymphoma, Mixed Cellularity Hodgkin Lymphoma, Nodular Sclerosing Hodgkin Lymphoma, Complete Blood Count (CBC), Blood Count
Related Glossary Terms: Reed-Sternberg Cells, Lymphatic Tissue, Radiation Therapy, Lymph Node Biopsy, Palliative Therapy, Lymphocytes, White Blood Cell (WBC), Stem Cell Transplantation, Stem Cell Transplant, PET Scan (Positron Emission Tomography), Clinical Trial, Chemotherapy, CAT or CT Scan (Computed Tomography Scan), Bone Marrow (BM)
 
RECENT NEWS
 
New drug combination brings 1-2 punch against acute leukemia Researchers at The University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation. More...
Mile High Amazing Race Downtown Denver 5/17 Get ready for the most AMAZING RACE for Life! Many have seen the television show; now here's a chance to race in your own adventure! The 2nd Annual Mile High Amazing race to Benefit The Leukemia, Lymphoma's Society is a one-day event that will be on Saturday, May 17, 2007 in Downtown Denver. More...
Stem Cell Transplant Procedures Vary Throughout the World Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas). These findings were published in the Journal of Clinical Oncology. More...
Arsenic-based therapy shown to help eradicate leukemia-initiating cells In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Known as either cancer initiating cells (CICs) or leukemia initiating cells (LICs), these stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear responsibility for the disease's reemergence. More...
Lenalidomide raises clot risk in multiple myeloma patients Thromboembolic events are increased in patients undergoing lenalidomide-based therapy for multiple myeloma, US and Italian researchers report. Aspirin prophylaxis appears to reduce this risk. More...
 
UPCOMING EVENTS
 
Young Adult Support Group If you are between the ages of 17 and 27 and are coping with cancer or a blood disorder, please join us. More...
Leukemia and Lymphoma Society Family Support Groups Looking for support aournd a diagnosis of Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Myeloma? The Leukemia and Lymphoma Society offers support groups for patients, family members, friends, a. More...
Family Member and Caregiver Support Group A weekly group for family members and caregivers of BMT patients to give and receive support, ask questions, swap ideas, be heard, listen and take a break. More...
BMT Reunion Pictures Attention BMT Reunion Participants Please click on the link below to view the pictures from the BMT Patient/Caregiver Reunion that was held on Saturday, October 13th, 2007. More...
 
RECENT CLINICAL TRIALS
 
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression after Conditioning with Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA Matched Family Donor Hematopoietic Cell Transplants More...
02057 - A Randomized Trial of Neulasta (Pegfilgrastim) Versus Neupogen (Filgrastim) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma More...
Treatment of Relapsed or Primary Refractory Hodgkin Lymphoma with High-Dose CBV Followed by Autologous Peripheral Blood Progenitor Cell Rescue More...
Urine Characteristics of Chronic Renal Dysfunction Following Myeloablative and Non-Myeloablative Hematopoietic Cell Transplantation More...
1581 - Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplant for Patients with STI-571 Responsive Ph+ Acute Leukemia - Multi-Center Trial More...
 
RECENT PATIENT STORIES
 
Bob Heykoop "People caring about one another represents life's greatest value." – Jim Rohn More...
George Poynter George Poynter would not be here today without the Rocky Mountain Blood and Marrow Transplant Program and its medical director, Dr. Jeff Matous. More...
Maggie Brunner In the weeks leading up to her transplant, Maggie Brunner and her husband had to ask each other some difficult questions. More...
Leslie Szabo What surprised Leslie most after her transplant was how long it took her to get back to what could be considered a relatively normal life. More...
Janice Gangl Not knowing what was wrong with me for so long was really terrifying. More...